Get 20% lifetime commission for referring investors to digrin.com
here.
Capricor Therapeutics, Inc. ( CAPR) - Key Metrics
CAPR Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0 | -$0.70 | $0 | $0 |
| 2026Q1 | $0 | -$0.59 | -$0.51 | -$0.70 |
| 2025Q4 | $0 | -$0.62 | -$0.48 | -$0.59 |
| 2025Q3 | $0 | -$0.54 | -$0.43 | -$0.52 |
| 2025Q2 | $0 | -$0.57 | -$0.44 | -$0.47 |
CAPR Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -8.60 |
| 2026Q1 | 0% | -12.88 |
| 2025Q4 | 0% | -11.64 |
| 2025Q3 | 0% | -3.34 |
| 2025Q2 | 0% | -4.36 |
CAPR
Price: $7.45
52 week price:
Earnings Per Share: -2.45 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 60100
Ebitda: -2.6 millionMarket Capitalization: 386.4 million